OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
20
Results
Show all
Save search
Copy query
Show results for
Unknown
(19)
Proteomics
(1)
Repository
MassIVE
(1)
Instrument Platform
LTQ Orbitrap Velos
(1)
Q Exactive
(1)
Publication Date
2019
(1)
Release Date
2020
(16)
2023
(2)
2024
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer
Explore This Study at the NCI Proteomic Data Commons
ORGANISM(S):
Homo Sapiens (ncbitaxon:9606)
2019-08-28
|
MSV000084246
|
MassIVE
Cite
A multi-country analysis of COVID-19 hospitalizations by vaccination status.
Not available
S-EPMC10935543
|
biostudies-literature
Cite
Relationship Between Severity of Ischemia and Coronary Artery Disease for Different Stress Test Modalities in the ISCHEMIA Trial.
Not available
S-EPMC11658795
|
biostudies-literature
Cite
The landscape of viral associations in human cancers.
Not available
S-EPMC8076016
|
biostudies-literature
Cite
Combined burden and functional impact tests for cancer driver discovery using DriverPower.
Not available
S-EPMC7002750
|
biostudies-literature
Cite
Pathway and network analysis of more than 2500 whole cancer genomes.
Not available
S-EPMC7002574
|
biostudies-literature
Cite
A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns.
Not available
S-EPMC7002586
|
biostudies-literature
Cite
Divergent mutational processes distinguish hypoxic and normoxic tumours.
Not available
S-EPMC7002770
|
biostudies-literature
Cite
Comprehensive molecular characterization of mitochondrial genomes in human cancers.
Not available
S-EPMC7058535
|
biostudies-literature
Cite
Pan-cancer analysis of whole genomes.
Not available
S-EPMC7025898
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets